Q1 2026 Revenue Up 7% to $711M, Net Income Down 3.6%; Completes $72M Acquisition, Continues Share Repurchase
RVTY sits 22% above its 52-week low of $81.22.
Summary
Revvity reported a 7% revenue increase to $711.1 million for Q1 2026, but net income decreased by 3.6% and gross margins compressed. The company completed a $72 million acquisition, continued its share repurchase program, and is preparing for a €500 million debt maturity in July.
Key Events · Earnings and Guidance · RVTY
-
Q1 2026 Financial Performance
Revenue increased 7% year-over-year to $711.1 million, while net income decreased 3.6% to $40.7 million. Gross margin declined by 200 basis points to 54.5% due to product mix, foreign exchange rates, and tariffs.
-
Strategic Acquisition Completed
Revvity acquired Advanced Chemistry Development Inc. (ACD/Labs) for $72.0 million in cash, plus up to $8.0 million in contingent consideration. This acquisition adds scientific software solutions to the Life Sciences segment.
-
Increased Restructuring Costs and Workforce Reduction
Restructuring and other costs rose to $10.7 million in Q1 2026, up from $3.2 million in the prior year, impacting approximately 2% of the workforce through severance and facility consolidations.
-
Active Share Repurchase Program
The company repurchased $79.0 million of common stock in Q1 2026 under its $1.0 billion program, with $800.5 million remaining authorized as of April 5, 2026. An additional $7.8 million was repurchased subsequent to the quarter end.
Analysis · RVTY · Industrial Applications And Services
This quarterly report provides detailed financial results for Q1 2026, confirming previously announced revenue growth but revealing a slight decline in net income and a 200 basis point drop in gross margin. The company also disclosed a strategic acquisition of Advanced Chemistry Development Inc. for $72 million in cash, alongside increased restructuring costs and a 2% workforce reduction. An active share repurchase program is ongoing, with $800.5 million remaining. Investors should monitor the upcoming maturity of €500 million in senior unsecured notes in July 2026 and the company's plans for repayment.
At the time of this filing, RVTY was trading at $99.30 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.1B. The 52-week trading range was $81.22 to $118.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.